{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=cephalosporins&page=2", "query": { "intervention": "cephalosporins", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 265, "total_pages": 27, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=cephalosporins&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=cephalosporins&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-06T06:57:01.044Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03485950", "title": "Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Other Infectious Diseases" ], "interventions": [ { "name": "Cefepime", "type": "DRUG" }, { "name": "Ceftolozane", "type": "DRUG" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Meropenem", "type": "DRUG" }, { "name": "Piperacillin-Tazobactam", "type": "DRUG" }, { "name": "Tazobactam", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2018-05-16", "completion_date": "2022-02-16", "has_results": true, "last_update_posted_date": "2022-03-15", "last_synced_at": "2026-10-06T06:57:01.044Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03485950" }, { "nct_id": "NCT07207876", "title": "Study of Ceftriaxone and Benzathine Penicillin G During Pregnancy", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pregnancy" ], "interventions": [ { "name": "Ceftriaxon", "type": "DRUG" }, { "name": "Benzathine penicillin G", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "International Maternal Pediatric Adolescent AIDS Clinical Trials Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "FEMALE", "summary": "Female only" }, "enrollment_count": 110, "start_date": "2026-02-16", "completion_date": "2027-09-30", "has_results": false, "last_update_posted_date": "2026-08-06", "last_synced_at": "2026-10-06T06:57:01.044Z", "location_count": 8, "location_summary": "Los Angeles, California • Chicago, Illinois • Stony Brook, New York + 2 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Stony Brook", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07207876" }, { "nct_id": "NCT04916951", "title": "Oral Amoxicillin and Cephalexin PK/PD in Neonates", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Neonatal Infection" ], "interventions": [ { "name": "Amoxicillin", "type": "DRUG" }, { "name": "Cephalexin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Day", "maximum_age": "60 Days", "sex": "ALL", "summary": "1 Day to 60 Days" }, "enrollment_count": 72, "start_date": "2021-07-14", "completion_date": "2025-11-30", "has_results": false, "last_update_posted_date": "2026-05-19", "last_synced_at": "2026-10-06T06:57:01.044Z", "location_count": 1, "location_summary": "Aurora, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT04916951" }, { "nct_id": "NCT05309304", "title": "Cefazolin PK Study 3g vs 2g", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Cefazolin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Baxter Healthcare Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 24, "start_date": "2022-02-14", "completion_date": "2022-08-30", "has_results": false, "last_update_posted_date": "2022-10-12", "last_synced_at": "2026-10-06T06:57:01.044Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05309304" }, { "nct_id": "NCT01912651", "title": "The Role of Antibiotics in Full Thickness Skin Graft Survival for Facial Reconstructive Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Facial Defect" ], "interventions": [ { "name": "cephalexin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Michigan", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 236, "start_date": "2011-09-22", "completion_date": "2025-11-07", "has_results": false, "last_update_posted_date": "2026-07-02", "last_synced_at": "2026-10-06T06:57:01.044Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT01912651" }, { "nct_id": "NCT03213249", "title": "Bacterial Biofilms in Reconstructive Breast Prostheses Following Mastectomy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Breast Implant Infection", "Mammoplasty" ], "interventions": [ { "name": "Normal saline", "type": "OTHER" }, { "name": "Cefazolin", "type": "DRUG" }, { "name": "Skin biopsy", "type": "PROCEDURE" }, { "name": "Bilateral skin- or nipple-sparing mastectomies", "type": "PROCEDURE" }, { "name": "Tissue expander", "type": "DEVICE" }, { "name": "Breast implant", "type": "DEVICE" }, { "name": "Autologous flap", "type": "PROCEDURE" }, { "name": "Acellular dermal matrix sling", "type": "OTHER" }, { "name": "Gentamicin", "type": "DRUG" }, { "name": "Bacitracin", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG", "PROCEDURE", "DEVICE" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "FEMALE", "summary": "18 Years to 75 Years · Female only" }, "enrollment_count": 19, "start_date": "2017-07-25", "completion_date": "2018-09-26", "has_results": false, "last_update_posted_date": "2019-02-08", "last_synced_at": "2026-10-06T06:57:01.044Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT03213249" }, { "nct_id": "NCT03862040", "title": "Cefiderocol Concentrations in the Lungs of Hospitalized Patients With Bacterial Pneumonia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Bacterial Pneumonia" ], "interventions": [ { "name": "Cefiderocol", "type": "DRUG" }, { "name": "Standard of Care Antibiotic", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Shionogi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 7, "start_date": "2019-02-20", "completion_date": "2019-10-15", "has_results": true, "last_update_posted_date": "2020-11-05", "last_synced_at": "2026-10-06T06:57:01.044Z", "location_count": 7, "location_summary": "Aurora, Colorado • Hartford, Connecticut • Jacksonville, Florida + 4 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Hartford", "state": "Connecticut" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03862040" }, { "nct_id": "NCT00835081", "title": "Cefadroxil 500 mg Capsules in Normal Healthy Non-Smoking Male and Female Subjects.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Cefadroxil 500 mg Capsules", "type": "DRUG" }, { "name": "DURICEF® capsules 500 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Pharmaceuticals USA", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 26, "start_date": "2004-09", "completion_date": "2004-10", "has_results": true, "last_update_posted_date": "2024-08-19", "last_synced_at": "2026-10-06T06:57:01.044Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00835081" }, { "nct_id": "NCT04278404", "title": "Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Coronavirus Infection (COVID-19)", "Pulmonary Arterial Hypertension", "Urinary Tract Infections in Children", "Hypertension", "Pain", "Hyperphosphatemia", "Primary Hyperaldosteronism", "Edema", "Hypokalemia", "Heart Failure", "Hemophilia", "Menorrhagia", "Insomnia", "Pneumonia", "Skin Infection", "Arrythmia", "Asthma in Children", "Bronchopulmonary Dysplasia", "Adrenal Insufficiency", "Fibrinolysis; Hemorrhage", "Attention Deficit Hyperactivity Disorder", "Multisystem Inflammatory Syndrome in Children (MIS-C)", "Kawasaki Disease", "Coagulation Disorder", "Down Syndrome" ], "interventions": [ { "name": "The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "0 Years", "maximum_age": "20 Years", "sex": "ALL", "summary": "0 Years to 20 Years" }, "enrollment_count": 5000, "start_date": "2020-03-05", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-08-21", "last_synced_at": "2026-10-06T06:57:01.044Z", "location_count": 49, "location_summary": "Phoenix, Arizona • Little Rock, Arkansas • Los Angeles, California + 40 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT04278404" }, { "nct_id": "NCT02433704", "title": "Preoperative Antibiotic Dosing for Total Knee Arthroplasty", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Acute Infection of Total Knee Replacement" ], "interventions": [ { "name": "New Intraosseous", "type": "DEVICE" }, { "name": "Cefazolin", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 0, "start_date": "2015-05", "completion_date": "2018-06", "has_results": false, "last_update_posted_date": "2017-07-28", "last_synced_at": "2026-10-06T06:57:01.044Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02433704" } ] }